109 related articles for article (PubMed ID: 9353108)
1. Genetic testing for Alzheimer's disease 'not appropriate'.
Lehrman S
Nature; 1997 Oct; 389(6654):898. PubMed ID: 9353108
[No Abstract] [Full Text] [Related]
2. Apolipoprotein E epsilon 4 allele (APOE epsilon 4) and Alzheimer's disease: role of genetic testing for diagnosis and risk assessment.
Tecnologica MAP Suppl; 1999 Apr; ():4-7. PubMed ID: 10848162
[No Abstract] [Full Text] [Related]
3. Advances in genetic testing for Alzheimer's disease.
Howard KL; Filley CM
Rev Neurol Dis; 2009; 6(1):26-32. PubMed ID: 19367221
[TBL] [Abstract][Full Text] [Related]
4. Alzheimer's disease genes and genetic testing in clinical practice.
Gaskell PC; Vance JM
JAAPA; 2004 Mar; 17(3):25-6, 29-30, 32. PubMed ID: 15314881
[No Abstract] [Full Text] [Related]
5. Genetic testing has no place as a routine diagnostic test in sporadic and familial cases of Alzheimer's disease.
van der Cammen TJ; Croes EA; Dermaut B; de Jager MC; Cruts M; Van Broeckhoven C; van Duijn CM
J Am Geriatr Soc; 2004 Dec; 52(12):2110-3. PubMed ID: 15571552
[TBL] [Abstract][Full Text] [Related]
6. Genetic testing and Alzheimer disease: the promise.
Roses AD
Alzheimer Dis Assoc Disord; 1998; 12 Suppl 3():S3-9. PubMed ID: 9876936
[No Abstract] [Full Text] [Related]
7. Disclosure of the genetic risk of Alzheimer's disease.
Gordon SC; Landa D
N Engl J Med; 2010 Jan; 362(2):181-2; author reply 182. PubMed ID: 20071713
[No Abstract] [Full Text] [Related]
8. Effect of genetic testing for risk of Alzheimer's disease.
Kane RA; Kane RL
N Engl J Med; 2009 Jul; 361(3):298-9. PubMed ID: 19605835
[No Abstract] [Full Text] [Related]
9. Ethical issues in genetic testing for Alzheimer's disease.
Kahn J
Geriatrics; 1997 Sep; 52 Suppl 2():S30-2. PubMed ID: 9307583
[TBL] [Abstract][Full Text] [Related]
10. Restrict genetic susceptibility tests.
Thomas S; Caldicott F; Barchard C; Bartlett R; Haldane J; Hornby S; McGuffin P; Pleming N; Richards M; Taylor P; Wilkie A; Young S
Nature; 1998 Sep; 395(6700):317. PubMed ID: 9759714
[No Abstract] [Full Text] [Related]
11. Genetic risk assessment for adult children of people with Alzheimer's disease: the Risk Evaluation and Education for Alzheimer's Disease (REVEAL) study.
Roberts JS; Cupples LA; Relkin NR; Whitehouse PJ; Green RC;
J Geriatr Psychiatry Neurol; 2005 Dec; 18(4):250-5. PubMed ID: 16306249
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein E genotyping for Alzheimer's disease: ethical concerns and implications for clinical practice.
Abyad A; al Imad R
J Med Liban; 1999; 47(5):291-4. PubMed ID: 10887530
[No Abstract] [Full Text] [Related]
13. Serum levels and genetic variation of TGF-beta1 are not associated with Alzheimer's disease.
Rodríguez-Rodríguez E; Sánchez-Juan P; Mateo I; Llorca J; Infante J; García-Gorostiaga I; Berciano J; Combarros O
Acta Neurol Scand; 2007 Dec; 116(6):409-12. PubMed ID: 17986101
[TBL] [Abstract][Full Text] [Related]
14. The ethics of disclosing genetic diagnosis for Alzheimer's disease: do we need a new paradigm?
Arribas-Ayllon M
Br Med Bull; 2011; 100():7-21. PubMed ID: 21672937
[TBL] [Abstract][Full Text] [Related]
15. Genetic testing and Alzheimer's disease.
Health News; 1998 Mar; 4(4):5. PubMed ID: 9553608
[No Abstract] [Full Text] [Related]
16. Get the facts about genetic testing.
Kuhn D
J Gerontol Nurs; 2003 Apr; 29(4):3; author reply 3. PubMed ID: 12710351
[No Abstract] [Full Text] [Related]
17. Prediction of individual clinical outcome in MCI by means of genetic assessment and (18)F-FDG PET.
Drzezga A; Grimmer T; Riemenschneider M; Lautenschlager N; Siebner H; Alexopoulus P; Minoshima S; Schwaiger M; Kurz A
J Nucl Med; 2005 Oct; 46(10):1625-32. PubMed ID: 16204712
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility testing for children.
Health Prog; 2003; 84(3):11-2, 50. PubMed ID: 12789851
[No Abstract] [Full Text] [Related]
19. The effect of APOE genotype on clinical phenotype in Alzheimer disease.
Borroni B; Di Luca M; Padovani A
Neurology; 2007 Feb; 68(8):624; author reply 624. PubMed ID: 17310043
[No Abstract] [Full Text] [Related]
20. Genetics. Once shunned, test for Alzheimer's risk headed to market.
Couzin J
Science; 2008 Feb; 319(5866):1022-3. PubMed ID: 18292309
[No Abstract] [Full Text] [Related]
[Next] [New Search]
